| 摘要 |
A method and device for augmenting the ability of T-cells, NK cells and other body cells, of a patient for fighting disease and invading diseased tissue, and for elevating the level of CD3 zeta expression in T cells for better functioning of these T-cells and their augmented capability to eliminate cancer and infectious organisms, by exposing, for a predetermined exposure period, the first substance of T-cell or other cells to a second substance having a T-cell-boosting capability, such as, but not limited to CD3 zeta elevating capability, increased CXCR4, CD147, 67-kDa laminin receptor and/or any other key receptor in T-cells capability, increased tissue invasion capability, TNFa elevating capability, to augment the ability of the separated cells to fight the disease; and following the predetermined exposure period, reintroducing the first substance of T-cells back into the blood of the subject. The first substance is exposed to the second substance by mixing the two substances in a mixing device providing hermetically-sealed conditions effective to maintain sterility in both substances during the mixing and to maintain tissue culture conditions required for the cells viability thereof and for the required exposure period. |
